Alexandria A Oviatt

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Urinary Tract Infection

Escherichia Coli

Top Venues

ACS infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandria A Oviatt, Elizabeth G Gibson, Jianzhong Huang, Karen Mattern, Keir C Neuman, Pan F Chan, Neil Osheroff
Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting. ACS infectious diseases 10 (4) (2024)
Jessica A Collins, Alexandria A Oviatt, Pan F Chan, Neil Osheroff
Target-Mediated Fluoroquinolone Resistance in Neisseria gonorrhoeae : Actions of Ciprofloxacin against Gyrase and Topoisomerase IV. ACS infectious diseases 10 (4) (2024)
Jessica A Collins, Alexandria A Oviatt, Pan F Chan, Neil Osheroff
Target-Mediated Fluoroquinolone Resistance in Neisseria gonorrhoeae : Actions of Ciprofloxacin against Gyrase and Topoisomerase IV. ACS infectious diseases 10 (4) (2024)
Jessica A Collins, Alexandria A Oviatt, Pan F Chan, Neil Osheroff
Target-Mediated Fluoroquinolone Resistance in Neisseria gonorrhoeae : Actions of Ciprofloxacin against Gyrase and Topoisomerase IV. ACS infectious diseases 10 (4) (2024)
Alexandria A Oviatt, Elizabeth G Gibson, Jianzhong Huang, Karen Mattern, Keir C Neuman, Pan F Chan, Neil Osheroff
Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting. ACS infectious diseases 10 (4) (2024)
Alexandria A Oviatt, Elizabeth G Gibson, Jianzhong Huang, Karen Mattern, Keir C Neuman, Pan F Chan, Neil Osheroff
Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting. ACS infectious diseases 10 (4) (2024)
Jessica A Collins, Alexandria A Oviatt, Pan F Chan, Neil Osheroff
Target-Mediated Fluoroquinolone Resistance in Neisseria gonorrhoeae : Actions of Ciprofloxacin against Gyrase and Topoisomerase IV. ACS infectious diseases 10 (4) (2024)
Alexandria A Oviatt, Elizabeth G Gibson, Jianzhong Huang, Karen Mattern, Keir C Neuman, Pan F Chan, Neil Osheroff
Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting. ACS infectious diseases 10 (4) (2024)
Alexandria A Oviatt, Elizabeth G Gibson, Jianzhong Huang, Karen Mattern, Keir C Neuman, Pan F Chan, Neil Osheroff
Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting. ACS infectious diseases 10 (4) (2024)
Alexandria A Oviatt, Elizabeth G Gibson, Jianzhong Huang, Karen Mattern, Keir C Neuman, Pan F Chan, Neil Osheroff
Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting. ACS infectious diseases 10 (4) (2024)
Jessica A Collins, Alexandria A Oviatt, Pan F Chan, Neil Osheroff
Target-Mediated Fluoroquinolone Resistance in Neisseria gonorrhoeae : Actions of Ciprofloxacin against Gyrase and Topoisomerase IV. ACS infectious diseases 10 (4) (2024)
Alexandria A Oviatt, Elizabeth G Gibson, Jianzhong Huang, Karen Mattern, Keir C Neuman, Pan F Chan, Neil Osheroff
Interactions between Gepotidacin and Escherichia coli Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting. ACS infectious diseases 10 (4) (2024)
Jessica A Collins, Alexandria A Oviatt, Pan F Chan, Neil Osheroff
Target-Mediated Fluoroquinolone Resistance in Neisseria gonorrhoeae : Actions of Ciprofloxacin against Gyrase and Topoisomerase IV. ACS infectious diseases 10 (4) (2024)
Elizabeth G Gibson, Alexandria A Oviatt, Monica Cacho, Keir C Neuman, Pan F Chan, Neil Osheroff
Bimodal Actions of a Naphthyridone/Aminopiperidine-Based Antibacterial That Targets Gyrase and Topoisomerase IV. Biochemistry 58 (44) (2019)